4.8 Review

Asthma in older adults

Journal

LANCET
Volume 376, Issue 9743, Pages 803-813

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(10)61087-2

Keywords

-

Funding

  1. NHMRC
  2. AstraZeneca
  3. Boehringer Ingelheim
  4. GlaxoSmithKline
  5. Novartis
  6. Pharmaxis
  7. National Health and Medical Research Council (NHMRC) Centre for Respiratory and Sleep Medicine
  8. Australian Department of Health and Ageing through the Australian Institute of Health and Welfare

Ask authors/readers for more resources

Asthma in older people is common and is characterised by underdiagnosis and undertreatment. Ageing is associated with unique issues that modify expression, recognition, and treatment of the disease. In particular, asthma and chronic obstructive pulmonary disease (COPD) both overlap and converge in older people. This concurrence, together with absence of precise diagnostic methods, makes diagnosis complex. A multidimensional assessment that addresses airway problems, comorbidities, risk factors, and management skills will draw attention to key needs for intervention. Increased attention to the complications of asthma and obstructive airway disease in older people is needed, specifically to develop effective systems of care, appropriate clinical practice guidelines, and a research agenda that delivers improved health outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available